CARB-X funds development of anti-biofilm vaccine
Clarametyx Biosciences will receive $2.6 million from CARB-X to develop CMTX-301, a vaccine designed to prevent bacterial biofilm formation.
Related Articles
Does the First U.S. Death Mean Bird Flu Is Getting More Dangerous?
Here’s what the latest genetic analysis reveals about how the virus is mutating.
Welcome! You are invited to join a webinar: New ID Add-On Code G0545. After registering, you will receive a confirmation email about joining the webinar.
New for 2025! ID has a new add on code (G0545) in Medicare that will affect your compensation! Join IDSA members, Amy Kressel and Asher…
Outcomes Associated With Blastomycosis in Solid Organ and Hematopoietic Cell Transplant Recipients
In this retrospective single center case series, we found that while rates of blastomycosis remain low among SOT and HCT recipients, infection is associated with…
Impact of HIV and Its Treatment on Weight and Body Habitus | Academy Clinical Education Center
2.5 CEUs Impact of HIV and Its Treatment on Weight and Body Habitus Webinar…
ACIP Expands Pneumococcal Vaccine Guidelines for Adults Aged 50 and Older
Updated recommendations simplify vaccine eligibility, favoring PCV21 while addressing cost-effectiveness and racial health disparities.
Office Hours with Earth’s Virology Professor Livestream 1/8/25 8 pm EDT
Join Vincent Racaniello for Office Hours to answer your questions about viruses – including SARS-CoV-2, Mpox virus, poliovirus, influenza virus, and more – o…
STI Reinfection Risk and Condom Use Vary By Age, Sexual Orientation
The risk for STI reinfection and condom use at last sexual encounter vary by age and sexual orientation among people in the UK aged 16…
Astronauts Experience Acute and Chronic Pain During and After Spaceflight
The incidence of acute and chronic pain was high among astronauts both during and after spaceflight, with many experiencing adverse spinal changes and low back…
The Hospitalization Rate Among Adults With RSV Infection Is High
The all-cause hospitalization rate at 28 days is high among adults with outpatient medically attended RSV infections.
Ending the HIV Epidemic in the US Success Stories
Read success stories from partners in the Ending the HIV Epidemic in the US campaign.
